
Japan start-up Innophys seeks to expand exoskeleton business abroad
Dec 31, 2022 23:09 pm UTC| Science Economy Business Health
Japan start-up Innophys Co. is expanding overseas in nations that have aging populations to offer its wearable exoskeleton to support heavy lifting. Set up by Tokyo University of Science professor Hiroshi Kobayashi,...

McDonald’s update on antibiotics policy hit as weaker approach
Dec 31, 2022 21:03 pm UTC| Health Economy Business
McDonalds Corp. has finally updated its antibiotics policy that calls for reduced antibiotic usage after a two-year delay. The fast-food giants new policy revealed in Decemebr follows guidelines set out by the World...

LG developing appliances using sleep analytics technology
Dec 31, 2022 18:13 pm UTC| Health Technology Economy Business
LG Electronics Inc. has collaborated with sleep-tracking software startup, Asleep, to develop smart home appliances that utilize sleep analytics technology. Under its memorandum of understanding with Asleep, LG will...

MBK acquires digital dental solution provider Medit
Dec 31, 2022 17:44 pm UTC| Business Economy Health
MBK Partners has acquired a 99.5 percent stake in Medit, a Seoul-based 3D dental scanner and solutions provider, from its largest shareholder, Unison Capital for 2.4 trillion won. The acquisition took place a month...

Volkswagen recalls 42,000 Beetles in N. America for airbag replacements
Dec 31, 2022 17:40 pm UTC| Business Economy Health
Volkswagen is recalling nearly 42,000 Beetles from the 2015 and 2016 model years in the US and Canada to replace their potentially dangerous Takata airbag inflators. According to the National Highway Traffic Safety...

Pfizer, GSK, Bristol Myers, AstraZeneca, Sanofi to raise prices on at least 350 drugs in US
Dec 31, 2022 17:29 pm UTC| Health Economy Business
Drugmakers including Pfizer Inc, GlaxoSmithKline PLC , Bristol Myers Squibb, AstraZeneca PLC and Sanofi SA will raise prices in the US on over 350 unique drugs in early January. The increases are in preparation for the...

Japan medical institutions to develop tailored drugs for rare diseases
Dec 30, 2022 23:40 pm UTC| Health Economy Business Science
Tokyo Medical and Dental University and the National Center of Neurology and Psychiatry are planning to develop tailored drugs for patients with genetic disorders to find treatment for extremely rare diseases. The two...
US–India Trade Turbocharge: Stocks Poised to Ride the Export Wave